Use of the Fagerström test for nicotine dependence as an instrument to measure nicotine dependence
Autor(a) principal: | |
---|---|
Data de Publicação: | 2007 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Clinical and Biomedical Research |
Texto Completo: | https://seer.ufrgs.br/index.php/hcpa/article/view/461 |
Resumo: | Tobacco smoking is considered the leading cause of avoidable death. Use of cigarettes presents correlation with increased incidence of atherosclerotic disease and could be the largest contributor to growth in risk of diseases combined with other factors. It is classified as nicotine dependence and is included in the group of mental disorders and behaviors caused by use of psychoactive substances by the World Health Organization. It is important to have an instrument to evaluate the degree of nicotine dependence in the management of smokers. There is a correlation between degree of nicotine dependence and response to different treatments. Smokers with lower degree of dependence can be treated only with the cognitive behavioral approach. Those with higher degree require pharmacological therapy. This review of literature showed that the Fagerström test for nicotine dependence (FTND) is used worldwide to evaluate severity of nicotine dependence. This article presents a review of FTND as an evaluation instrument in the management of smokers. |
id |
UFRGS-20_d5c8e580faec9a001687a1f99d861e38 |
---|---|
oai_identifier_str |
oai:seer.ufrgs.br:article/461 |
network_acronym_str |
UFRGS-20 |
network_name_str |
Clinical and Biomedical Research |
repository_id_str |
|
spelling |
Use of the Fagerström test for nicotine dependence as an instrument to measure nicotine dependenceUtilização do teste de dependência à nicotina de Fagerström como um instrumento de medida do grau de dependênciaTabagismoDoenças CardiovascularesTabagismoDoenças CardiovascularesTobacco smoking is considered the leading cause of avoidable death. Use of cigarettes presents correlation with increased incidence of atherosclerotic disease and could be the largest contributor to growth in risk of diseases combined with other factors. It is classified as nicotine dependence and is included in the group of mental disorders and behaviors caused by use of psychoactive substances by the World Health Organization. It is important to have an instrument to evaluate the degree of nicotine dependence in the management of smokers. There is a correlation between degree of nicotine dependence and response to different treatments. Smokers with lower degree of dependence can be treated only with the cognitive behavioral approach. Those with higher degree require pharmacological therapy. This review of literature showed that the Fagerström test for nicotine dependence (FTND) is used worldwide to evaluate severity of nicotine dependence. This article presents a review of FTND as an evaluation instrument in the management of smokers.O tabagismo é considerado a maior causa de morte evitável. O número de cigarros consumidos apresenta correlação com o aumento de incidência da doença aterosclerótica, podendo ser o maior contribuinte para o aumento do risco de doença em combinação com outros fatores de risco. É classificado como dependência de nicotina e está incluído no grupo de transtornos mentais e de comportamentos decorrentes do uso de substâncias psicoativas segundo a classificação da Organização Mundial da Saúde. No manejo de pacientes tabagistas, a utilização de um instrumento para avaliar o grau de dependência de nicotina é muito importante. Existe uma correlação entre nível de dependência nicotínica e resposta às diversas terapias. Pacientes com nível de dependência baixa poderão ser tratados apenas com abordagem cognitivo-comportamental. Os de grau mais elevado de dependência necessitarão de terapia farmacológica. Nesta revisão, observa-se que o teste de dependência à nicotina de Fagerström (FTND) é utilizado mundialmente para avaliar a gravidade da dependência. Esse artigo apresenta uma revisão da literatura sobre o FTND como instrumento de avaliação no manejo de pacientes tabagistas.HCPA/FAMED/UFRGS2007-11-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliados por Paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/461Clinical & Biomedical Research; Vol. 27 No. 3 (2007): Revista HCPAClinical and Biomedical Research; v. 27 n. 3 (2007): Revista HCPA2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/461/1647Pietrobon, Rosa CecíliaBarbisan, Juarez NeuhausManfroi, Waldomiro Carlosinfo:eu-repo/semantics/openAccess2020-01-16T16:14:10Zoai:seer.ufrgs.br:article/461Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2020-01-16T16:14:10Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.none.fl_str_mv |
Use of the Fagerström test for nicotine dependence as an instrument to measure nicotine dependence Utilização do teste de dependência à nicotina de Fagerström como um instrumento de medida do grau de dependência |
title |
Use of the Fagerström test for nicotine dependence as an instrument to measure nicotine dependence |
spellingShingle |
Use of the Fagerström test for nicotine dependence as an instrument to measure nicotine dependence Pietrobon, Rosa Cecília Tabagismo Doenças Cardiovasculares Tabagismo Doenças Cardiovasculares |
title_short |
Use of the Fagerström test for nicotine dependence as an instrument to measure nicotine dependence |
title_full |
Use of the Fagerström test for nicotine dependence as an instrument to measure nicotine dependence |
title_fullStr |
Use of the Fagerström test for nicotine dependence as an instrument to measure nicotine dependence |
title_full_unstemmed |
Use of the Fagerström test for nicotine dependence as an instrument to measure nicotine dependence |
title_sort |
Use of the Fagerström test for nicotine dependence as an instrument to measure nicotine dependence |
author |
Pietrobon, Rosa Cecília |
author_facet |
Pietrobon, Rosa Cecília Barbisan, Juarez Neuhaus Manfroi, Waldomiro Carlos |
author_role |
author |
author2 |
Barbisan, Juarez Neuhaus Manfroi, Waldomiro Carlos |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Pietrobon, Rosa Cecília Barbisan, Juarez Neuhaus Manfroi, Waldomiro Carlos |
dc.subject.por.fl_str_mv |
Tabagismo Doenças Cardiovasculares Tabagismo Doenças Cardiovasculares |
topic |
Tabagismo Doenças Cardiovasculares Tabagismo Doenças Cardiovasculares |
description |
Tobacco smoking is considered the leading cause of avoidable death. Use of cigarettes presents correlation with increased incidence of atherosclerotic disease and could be the largest contributor to growth in risk of diseases combined with other factors. It is classified as nicotine dependence and is included in the group of mental disorders and behaviors caused by use of psychoactive substances by the World Health Organization. It is important to have an instrument to evaluate the degree of nicotine dependence in the management of smokers. There is a correlation between degree of nicotine dependence and response to different treatments. Smokers with lower degree of dependence can be treated only with the cognitive behavioral approach. Those with higher degree require pharmacological therapy. This review of literature showed that the Fagerström test for nicotine dependence (FTND) is used worldwide to evaluate severity of nicotine dependence. This article presents a review of FTND as an evaluation instrument in the management of smokers. |
publishDate |
2007 |
dc.date.none.fl_str_mv |
2007-11-29 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article Avaliados por Pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/461 |
url |
https://seer.ufrgs.br/index.php/hcpa/article/view/461 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/461/1647 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
dc.source.none.fl_str_mv |
Clinical & Biomedical Research; Vol. 27 No. 3 (2007): Revista HCPA Clinical and Biomedical Research; v. 27 n. 3 (2007): Revista HCPA 2357-9730 reponame:Clinical and Biomedical Research instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Clinical and Biomedical Research |
collection |
Clinical and Biomedical Research |
repository.name.fl_str_mv |
Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
||cbr@hcpa.edu.br |
_version_ |
1799767051164712960 |